An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet medical journal. Lenacapavir stops ...
the HIV/AIDS research community can breathe a sigh of relief: The vaccine candidate does appear to offer a real, albeit modest, level of protection against HIV infection. Human Immunodeficiency ...
Some short-term policies are available for people doing well on HIV treatment. If your employer offers income protection as an employee benefit, your HIV status will not usually be an issue. If you ...
but you wouldn’t be able to claim for an HIV-related illness. Mortgage payment protection insurance is designed to cover your mortgage payments if you can’t work due to illness or injury, usually for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results